HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC

NCT07364305 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

ICC
Advanced Cancer

Interventions

DRUG: PD-L1 inhibitor
PROCEDURE: HAIC

Sponsor

Eastern Hepatobiliary Surgery Hospital